Category: Healthcare

  • Clinical Information System (CIS) Market

    —

    by

    The global clinical information system (CIS) market is anticipated to grow substantially, with its market size projected to increase from USD 1,208.0 million in 2024 to USD 2,414.8 million by 2034, reflecting a robust compound annual growth rate (CAGR) of 9.0%

  • Cirrhosis Management Market

    —

    by

    The global cirrhosis management market is projected to achieve a valuation of USD 726 million in 2024, expanding to approximately USD 1,053.3 million by 2034, at a compound annual growth rate (CAGR) of 4.8%

  • Clinical Next-Generation Sequencing (NGS) Data Analysis Market

    —

    by

    The global clinical next-generation sequencing (NGS) data analysis market is expected to witness remarkable growth, with a projected valuation of USD 3.3 billion in 2024, reaching USD 14.1 billion by 2034, growing at a robust compound annual growth rate (CAGR) of 18.4%.

  • Clinical Nutrition Market

    —

    by

    The global clinical nutrition market is poised for robust growth, with its market size projected to expand from USD 14.4 billion in 2024 to USD 30.2 billion by 2034, registering a compound annual growth rate (CAGR) of 9.1%

  • Clinical Oncology Next-Generation Sequencing (NGS) Market

    —

    by

    The global clinical oncology next-generation sequencing (NGS) market is poised for significant growth, with an estimated market valuation of USD 636 million in 2024, projected to surge to USD 4.1 billion by 2034, achieving an impressive compound annual growth rate (CAGR) of 18.3%.

  • Clinical Research Organization (CRO) Market

    —

    by

    The global clinical research organization (CRO) market is poised for significant growth, with its value projected to expand from USD 63.43 billion in 2024 to USD 140.56 billion by 2034, registering a robust compound annual growth rate (CAGR) of 9.4%

  • Clinical Risk Grouping Solution Market

    —

    by

    The global clinical risk grouping solution market is expected to grow significantly, with a revised market valuation of USD 606.7 million in 2024, projected to reach USD 2.381 billion by 2034. This expansion represents a robust compound annual growth rate (CAGR) of 15.7%

  • Clinical Trial Biorepository and Archiving Solutions Market

    —

    by

    The global clinical trial biorepository and archiving solutions market is set to witness remarkable growth, with its value projected to increase from USD 4,877.7 million in 2024 to USD 14.7 billion by 2034, expanding at a robust compound annual growth rate (CAGR) of 11.9%

  • Clinical Trials Market

    —

    by

    The global clinical trials market is anticipated to reach a valuation of USD 121.97 billion in 2024, growing steadily to USD 185.61 billion by 2034, with a compound annual growth rate (CAGR) of 5.3%

  • Closed System Transfer Devices (CSTDs) Market

    —

    by

    The global closed system transfer devices (CSTDs) market is expected to expand significantly, with its value projected to increase from USD 1,029.8 million in 2024 to USD 2,283.5 million by 2034, registering a robust compound annual growth rate (CAGR) of 9.3%